The Home of Clinical Trials
MAC Clinical Research is one of Europe’s largest contract research organisations (CRO) and has headquarters in the UK. Owning a network of Dedicated Research Sites providing extensive reach, MAC also has offices within the EU and the US. Read more …
Latest Clinical Research News
Corporate
First Patient Dosed in Phase 1b Study for Generalised Anxiety Disorder
MAC Clinical Research has reached a key milestone in a Phase 1b study sponsored by Newleos Therapeutics investigating NTX-1955, a
April 8, 2026
Corporate
Positive Topline Results for Phase 2a Study in Social Anxiety Disorder
MAC Clinical Research is pleased to announce positive topline results from AtaiBeckley’s exploratory Phase 2a clinical trial evaluating an investigational
March 10, 2026
Corporate
Positive Topline Results for Phase 2a Study in Major Depressive Disorder
MAC Clinical Research is proud to have partnered with Gilgamesh Pharma in the successful completion of a Phase 2a clinical
February 13, 2026